Data Variables and Analysis Services
ID: 75N99224i000XXType: Sources Sought
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

PSC

SPECIAL STUDIES/ANALYSIS- SCIENTIFIC DATA (B529)
Timeline
    Description

    Sources Sought HEALTH AND HUMAN SERVICES, DEPARTMENT OF NATIONAL INSTITUTES OF HEALTH is seeking Data Variables and Analysis Services for the Advanced Research Projects Agency for Health (ARPA-H) Resilient Systems Office (RSO). The purpose of this procurement is to support the Market Overhaul to Reward Public Health Elevation in the United States (MORPHEUS) program Outcome Toolkit. ARPA-H is looking for data variables in the areas of maternal health, heart attack and stroke risk, opioid overdose, and alcohol-related health harms. This data will be used to calculate baseline rates of selected health outcomes for targeted geographies, allowing for targeted interventions and real-time evaluation of improvements.

    Point(s) of Contact
    Files
    Title
    Posted
    Lifecycle
    Title
    Type
    Sources Sought
    Similar Opportunities
    PROactive Solutions for Prolonging Resilience (PROSPR)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program. This initiative aims to extend the healthspan of Americans by developing interventions that address the underlying causes of age-related health decline, including the establishment of a predictive Intrinsic Capacity score and the repurposing of FDA-approved drugs. The program emphasizes a structured, multidisciplinary approach over a five-year timeline, focusing on key milestones such as in-home assessment technologies and decentralized clinical trials to create innovative preventative care models. Interested proposers are encouraged to reach out to the PROSPR Team at PROSPR@arpa-h.gov for inquiries, and further details can be found at the ARPA-H website. The final solicitation is anticipated to be published at a later date.
    Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
    Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
    Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
    Final Innovative Solutions Opening (ISO) ARPA-H Rare Disease AI/ML for Precision Integrated Diagnostics (RAPID)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Final Innovative Solutions Opening (ISO) titled "Rare Disease AI/ML for Precision Integrated Diagnostics" (RAPID). This initiative aims to enhance the diagnostic processes for rare diseases by developing advanced diagnostic support tools and optimizing large-scale health data collection, particularly focusing on underdiagnosed populations. The RAPID program is critical for addressing the prolonged diagnostic odysseys faced by millions of rare disease patients, with a structured approach that includes aggregating existing health data, collecting novel patient data, and creating a Rare Disease Data Commons for analytical evaluation. Interested parties can direct inquiries to the RAPID Email Box at RAPID@ARPA-H.gov, and should note that the program will operate over a proposed 4.5-year span, with specific milestones and evaluation criteria to ensure effective project execution.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) initiative. This program aims to develop innovative biosensor technologies for the continuous monitoring of tear biomarkers and AI-driven therapeutic delivery systems, particularly targeting conditions such as dry eye disease (DED). The initiative emphasizes collaboration among commercial entities and academic institutions to enhance diagnostic and treatment capabilities, ultimately striving to improve patient outcomes and healthcare accessibility. Interested parties should contact the OCULAB Team at OCULAB@ARPA-H.gov for further details, with multiple awards anticipated as part of this funding opportunity.
    ARPA-H ImagiNg Data EXchange (INDEX)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) program aimed at enhancing access to medical imaging data. The primary objective is to develop a sustainable platform that connects medical imaging data providers with researchers and developers, leveraging artificial intelligence and machine learning to address the shortage of qualified radiologists and improve healthcare outcomes. This initiative is critical for advancing algorithm development and clinical studies by creating a comprehensive repository of diverse imaging datasets, including cancer digital pathology and surgical videos. Interested parties must submit their Solution Summary by January 28, 2025, with the full proposal due by March 27, 2025. For further inquiries, contact the INDEX Team at INDEX@arpa-h.gov.
    ARPA-H Rare Disease AI/ML and Precision Integrated Diagnostics (RAPID) Patients’ Day
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a virtual event titled RAPID Patients’ Day on February 25, 2025, aimed at introducing the RAPID Program focused on utilizing artificial intelligence (AI) and machine learning (ML) for precision diagnostics in rare diseases. This event will provide insights into the ARPA-H mission, program goals, and the role of Patient Experience (PX) Partners, encouraging participation from patient advocacy groups to foster engagement and collaboration. The RAPID Program seeks to alleviate the diagnostic challenges faced by rare disease patients by developing innovative diagnostic tools and integrating comprehensive data, with registration for the event opening on December 19, 2024, and closing on February 21, 2025. Interested participants can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information.
    Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Computational ADME Tox AnaLYsis for Safer Therapeutics (CATALYST) Innovative Solutions Opening. This initiative aims to develop innovative in silico human physiology modeling platforms that enhance drug safety assessments and reduce reliance on animal testing in preclinical studies, focusing on leveraging AI/ML for ADME-Tox simulations. The program is structured in two phases, with Phase I dedicated to developing predictive tools and Phase II aimed at integrating these tools into regulatory submissions for IND-enabling studies. Interested parties must submit a solution summary by November 25, 2024, and proposals by February 14, 2025, with all submissions made through the designated online platforms. For further inquiries, contact the CATALYST team via email at CATALYST@arpa-h.gov.
    BARDA DRIVe EZ-BAA-22-100-SOL-00003
    Buyer not available
    Solicitation: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking HEALTH R&D SERVICES, HEALTH CARE SERVICES, and EXPERIMENTAL DEVELOPMENT through the BARDA DRIVe EZ-BAA-22-100-SOL-00003. This procurement is a reissuance of the BARDA DRIVe EZ-BAA and supersedes prior iterations such as BAA-20-100-SOL-0002. For more information, please visit https://drive.hhs.gov/.